VitelyBio

01/01/2024

May the New Year bring you joy, peace, and endless opportunities! Wishing everyone a Happy New Year filled with love, laughter, and success.

25/12/2023

25/11/2023

Discover the ultimate in Microbiology Testing Services with Vitely Bio. Our extensive knowledge in the segment, ensures precise testing and efficient timelines, providing absolute certainty in results.
To know more about us, visit www.vitely.com or write to Yogesh Chaudhari at: info@vitely.com or ychaudhari@vitely.com

20/11/2023

Vitely Bio, an analytical contract research organization, offers comprehensive range of In-Vitro bioequivalence, In-Vitro release and analytical development services. You can now directly talk to our experts Yogesh Chaudhari at CPHI India to discuss about challenges you have encountered, and how can help you mitigate them.

To know more about us, visit www.vitely.com or write to Yogesh Chaudhari at: info@vitely.com or ychaudhari@vitely.com

18/08/2023

Analyzing nitrosamines presents a challenging task due to the need to quantify ultra-low levels of these impurities across diverse and complex matrices, followed by the validation of developed methods to ensure compliance with GMP requirements.
Vitely Bio is fully equipped with ultra-modern instrumentation, such as LC-MS/MS and GC-MS/MS systems, to effectively analyze the nitrosamine levels.

12/08/2023

Vitely Bio is exhibiting at conference, October 24-26 in Barcelona. Stop by our Booth (Hall #1) and meet Yogesh Chaudhari to discuss how our expertise in the area of in vitro bioequivalence studies, in vitro characterization studies and analytical solutions can simplify and accelerate your drug approval process.
To know more or book a meeting, write to us at ychaudhari@vitely.com / info@vitely.com

17/07/2023

Do you have queries related to Biowaiver studies?
Write to yogesh chaudhary (ychaudhari@vitely.com) from our team to discuss how Vitely Bio’s experience, technical capabilities and approach in the area of Biowavier studies can simplify and accelerate your drug approval process.